Carcinoma, Non-Small-Cell Lung: all 6,645 studies
Page 47 of 67. Open to participants first (1,667), then studies with results posted, then the rest; newest registration first within each.
- A Trial to Compare the Efficacy, Safety, Pharmacokinetics and Immunogenicity of HD204 to Avastin® in Advanced Non-squamous Non-small Cell Lung Cancer PatientsActive, not recruitingNCT03390686Phase 3
- A Study Evaluates the Safety, Pharmacokinetics and Efficacy of WX-0593 in Advanced Solid Tumor PatientsStatus unknownNCT03389815Phase 1/2
- Pulmonary Physiology and Systemic Inflammatory in EO Pulmonary Events With Brigatinib Use in NSCLC and Other DiseasesCompletedNCT03389399
- BPI-7711 Capsule in Patients With EGFR Mutation T790M Positive Non-small Cell Lung CancerCompletedNCT03386955Phase 1/2
- Retreatment With Epidermal Growth Factor Receptor(EGFR) Tyrosine Kinase Inhibitor in EGFR Mutation Positive PatientsStatus unknownNCT03382795Phase 2
- A Phase III, Randomized, Multi-center Study to Determine the Efficacy of the Intercalating Combination Treatment of Chemotherapy and Gefitinib or Chemotherapy as Adjuvant Treatment in NSCLC With Common EGFR Mutations.Status unknownNCT03381066Phase 3
- A Personal Cancer Vaccine (NEO-PV-01) With Pembrolizumab and Chemotherapy for Patients With Lung CancerCompletedNCT03380871Phase 1
- Pembrolizumab (MK-3475) as Maintainance in Treated Patients With Unresectable Stage III NSCLCStatus unknownNCT03379441Phase 2
- Apatinib in Advanced Non-squamous，NSCLCStatus unknownNCT03376191
- Safety and Efficacy of Xalkori ROS1CompletedNCT03375242
- Pemetrexed/Cisplatin Intercalating Gefitinib Treating EGFR Wild NSCLCStatus unknownNCT03374280Phase 2
- A Prospective Study of Constructing Immune Repertoire to Monitor the Therapeutic Effect in NSCLC PatientsStatus unknownNCT03373955
- Efficacy Study of Comprehensive Rehabilitation Program Plus Chemotherapy in Postoperative NSCLC PatientsStatus unknownNCT03372694Phase 3
- Pilot Study of Nilogen 3D-EX and Its Ability to Predict Therapeutic Response to Anti-PD1 or Anti-PDL1 in NSCLCStatus unknownNCT03371992Early Phase 1
- A Phase II Trial of Cisplatin-Docetaxel Induction Plus Concurrent 3-D Conformal Radiotherapy and Weekly ChemotherapyCompletedNCT03371550Phase 2
- CPI-613 and Docetaxel in Treating Patients With Stage IIIB or IV Non-small Cell Lung CancerWithdrawnNCT03370159Phase 1/2
- Haploidentical NK Cells After Pemetrexed in Patients With Stage IV Non-Small Cell Lung Cancer (NSCLC)CompletedNCT03366064Phase 1
- Verification of Novel Survival Prediction Algorithm for Patients With NSCLC Spinal MetastasisStatus unknownNCT03363685
- Evaluate Safety, Tolerability, Pharmacokinetics and Anti-tumor Activity of AZD3759CompletedNCT03360929Phase 1/2
- Nivolumab and Ipilimumab Versus Chimiotherapy in First Line Treatment in PS 2 or Elderly in Advanced NSCLC PatientsCompletedNCT03351361Phase 3
- Icotinib as Neoadjuvant and Adjuvant Therapy in EGFR-mutant Stage IIIB or Oligometastasis Non-small Cell Lung CancerStatus unknownNCT03349203Phase 2
- Stereotactic Body Radiation Therapy Followed by Surgery in Treating Patients With Stage I-IIIA Non-small Cell Lung CancerTerminatedNCT03348748Early Phase 1
- Durvalumab (MEDI4736) in Frail and Elder Patients With Metastatic NSCLC (DURATION)CompletedNCT03345810Phase 2
- Explore Intra-tumor Heterogeneity and Prognostic Value of Postoperative Blood ctDNA of ⅡA - ⅢA Stage Non-squamous NSCLC Based on the Capture-based Sequencing and UMI Technology of Burning RockStatus unknownNCT03337711
- Exercise Intervention During Chemotherapy in Advanced Lung Cancer PatientsStatus unknownNCT03334071Not applicable
- Comparison of Post-operative Pain and Quality of Life Between Subxiphoid and Intercostal VATS for Lung CancerCompletedNCT03331588Phase 3
- Hypofractionated vs. Conventionally Fractionated Concurrent CRT for Unresectable Stage III NSCLCStatus unknownNCT03331575Phase 3
- Phase 1b DV281 With an Anti-PD-1 Inhibitor in NSCLCCompletedNCT03326752Phase 1
- Calypso Guided High Precision Stereotactic Ablative Radiosurgery for Lung TUmours Using Real-Time Tumour Tracking & Respiratory GatingActive, not recruitingNCT03322072Not applicable
- A Study of the Safety of Atezolizumab in Participants With Locally Advanced or Metastatic Non Small Cell Lung Cancer in ArgentinaCompletedNCT03321695
- FATE-NK100 as Monotherapy and in Combination With Monoclonal Antibody in Subjects With Advanced Solid TumorsCompletedNCT03319459Phase 1
- Combination of Durvalumab and Tremelimumab as Maintenance Treatment in Patients With Non Squamous and Squamous (NSCLC)WithdrawnNCT03319316Phase 2
- Pilot Study to Investigate The Diagnostic Yield and Utility of 22g and 19g Endobronchial Ultrasound Transbronchial Needle AspirateCompletedNCT03311620Not applicable
- SUNSET: SBRT for Ultra-central NSCLC- a Safety and Efficacy TrialActive, not recruitingNCT03306680Phase 1
- Radiomics to Identify Patients at Risk for Developing Pneumonitis, Differentiate Immune Checkpoint Inhibitor-induced Pneumonitis From Other Lung Inflammation and Distinguish Tumour Pseudo-progression From Real Tumour GrowthCompletedNCT03305380
- Immunotherapy by Nivolumab for HIV+ PatientsCompletedNCT03304093Phase 2
- The Pharmacokinetics and Safety of Single-dose and Parallel Comparisons in Patients With NSCLC Treated With JS001CompletedNCT03301688Phase 1
- Clinical Trial of the Efficacy and Safety of AC0010 in the Treatment of EGFR T790M Patients With Advanded NSCLCStatus unknownNCT03300115Phase 2
- Clinical Implementation of TNM-immunoscore in Resected Non-small Cell Lung CancerActive, not recruitingNCT03299478
- A Study of Autogene Cevumeran (RO7198457) as a Single Agent and in Combination With Atezolizumab in Participants With Locally Advanced or Metastatic TumorsCompletedNCT03289962Phase 1
- Clinical Effectiveness Assessment of VeriStrat® Testing and Validation of Immunotherapy Tests in NSCLC SubjectsActive, not recruitingNCT03289780
- Efficacy, Safety and Pharmacokinetics of BCD-100 (Anti-PD-1) Monotherapy as Second Line Treatment in Patients With Non-Small Cell Lung Cancer (DOMINUS)Status unknownNCT03288870Phase 2/3
- Treatment of Non-small Cell Lung Cancer With Cytokine-induced Killer (CIK) Cells Blocked by PD-1 AntibodyStatus unknownNCT03282435Phase 1
- Phase Ib Study of Stereotactic Body Radiotherapy (SBRT) in Oligometastatic Non-small Lung Cancer (NSCLC) With Dual Immune Checkpoint InhibitionTerminatedNCT03275597Phase 1
- PBF-1129 in Patients With NSCLCActive, not recruitingNCT03274479Phase 1
- A Retrospective Study of the Effectiveness and Safety of Nivolumab in Advanced/Metastatic Non-Small Cell Lung Cancer (NSCLC) Patients in JapanCompletedNCT03273790
- Feasibility Study of the RF Ablation Catheter to Ablate Lung TumorsTerminatedNCT03272971Not applicable
- Treatment Registry of Alectinib in Anaplastic Lymphoma Kinase (ALK)-Positive, Locally Advanced or Metastatic Non-Small Cell Lung Cancer in KoreaCompletedNCT03271554
- A Dose-Finding Study of the Second Mitochondrial Activator of Caspases (SMAC) Mimetic Debio 1143 When Given in Combination With Avelumab to Participants With Advanced Solid Malignancies and to Participants With Advanced or Metastatic Non-Small Cell Lung Cancer (NSCLC) After Platinum-Based TherapyCompletedNCT03270176Phase 1
- VX15/2503 in Combination With Avelumab in Advanced Non-small Cell Lung CancerCompletedNCT03268057Phase 1/2
- Gefitinib With Chemotherapy or Anti-angiogenesis in NSCLC Patients With Bim Deletion or Low EGFR Mutation AbundanceStatus unknownNCT03267654Phase 2
- Correlation Between Tissue and Plasmatic EGFR in CBNPC With EGFR Mutation or Predictive Factor of EGFR MutationTerminatedNCT03265496Not applicable
- the Clinical Trial of Gefitinib(Non - Small Cell Lung Cancer)Status unknownNCT03264794Phase 4
- Nab-Paclitaxel Versus Paclitaxel Plus Carboplatin in Advanced Squamous Cell Non Small Cell Lung CancerStatus unknownNCT03262948Phase 3
- U3-1402 in Metastatic or Unresectable Non-Small Cell Lung CancerActive, not recruitingNCT03260491Phase 1
- A Translational Study Investigating PD-L1 Expression After Radiotherapy for Non-small Cell Lung CancerCompletedNCT03258788
- IMRT and Timing in Combination With EGFRTKI for Stage IV Non-small-cell Lung CancerStatus unknownNCT03258671Not applicable
- Study of AZD9291 in NSCLC Patients Harboring T790M Mutation Who Failed EGFR TKI and With Brain and/or LMSStatus unknownNCT03257124Phase 2
- Compare Apatinib Plus Chemotherapy Drug Versus Chemotherapy Drug as Second-line Treatment in NSCLCTerminatedNCT03256721Phase 2
- Pembrolizumab in Combination With Radiotherapy in Locally Advanced Non-Small Cell Lung Cancer (NSCLC)WithdrawnNCT03245177Phase 1
- Efficacy Study of Comprehensive Rehabilitation Program in Postoperative NSCLC PatientsStatus unknownNCT03244605Phase 3
- Study of Oral cMET Inhibitor INC280 in Chinese Patients With EGFR Wild-type Advanced Non-small Cell Lung Cancer (NSCLC)WithdrawnNCT03240393Phase 2
- Detection of Either the EML4-ALK Gene Rearrangements or the T790M EGFR Mutation in the Plasma of Advanced NSCLC PatientsStatus unknownNCT03236675
- Cancer Panel From Blood of Lung Cancer PatientsStatus unknownNCT03235765
- A Study of Atezolizumab (Tecentriq®) in Ministry of Food and Drug Safety (MFDS)-Approved Indication(s)CompletedNCT03232593
- Phase I Study of SPH1188-11 in NSCLCWithdrawnNCT03231475Phase 1
- QUILT-3.055: A Study of Combination Immunotherapies in Patients Who Have Previously Received Treatment With Immune Checkpoint InhibitorsActive, not recruitingNCT03228667Phase 2
- The Predicted Potential of Quantitative T Cell Repertoire(TCR) in Anti-PD-L1 Treatment in NSCLC PatientsStatus unknownNCT03228368
- Olmutinib Trial in T790M (+) NSCLC Patients Detected by Liquid Biopsy Using BALF Extracellular Vesicular DNACompletedNCT03228277Phase 2
- Trametinib and Pembrolizumab in Treating Patients With Recurrent Non-small Cell Lung Cancer That Is Metastatic, Unresectable, or Locally AdvancedActive, not recruitingNCT03225664Phase 1/2
- UCDCC#269: A Pilot Study of Interlesional IL-2 and RT in Patients With NSCLC.CompletedNCT03224871Early Phase 1
- Efficacy and Safety of Osimertinib for HK Chinese With Metastatic T790M Mutated NSCLC-real World Setting.CompletedNCT03219970
- Epacadostat (INCB24360) in Combination With Sirolimus in Advanced MalignancyActive, not recruitingNCT03217669Phase 1
- Mediastinal Staging Accuracy of a Selective Lymphadenectomy Strategy in Early Stage NSCLC (ECTOP-1003)CompletedNCT03216551
- X-396 Capsule in Patients With ALK-positive Non-small Cell Lung Cancer Previously Treated With CrizotinibActive, not recruitingNCT03215693Phase 2
- Phase 1 Study of CK-301 (Cosibelimab) as a Single Agent in Subjects With Advanced CancersActive, not recruitingNCT03212404Phase 1
- Neo-MASCT Immunotherapy for Advanced NSCLC.Status unknownNCT03205930Phase 1/2
- A Phase IB/II Study of Alectinib Combined With Cobimetinib in Advanced ALK-Rearranged (ALK+) NSCLCActive, not recruitingNCT03202940Phase 1/2
- Apatinib Combine With Platinum-Based Doublet Chemotherapy for First-line Treatment of Advanced NSCLCStatus unknownNCT03201146Phase 1/2
- Dexamethasone, Flurbiprofen Axetil and Delirium After Lung Cancer SurgeryTerminatedNCT03200600Phase 4
- Prognostic PET/CT Model in Non Small Cell Lung CancerCompletedNCT03199599
- Clinical Efficacy and Safety of NK and NKT Cells Infusion in Patients With Non Small Cell Lung CancerStatus unknownNCT03198923Phase 1
- Vapor Ablation for Localized Cancer Lesions of the Lung (VAPORIZE)CompletedNCT03198468Not applicable
- Huaier Granule for Prevention of Recurrence and Metastasis of Stage II and III Non-small Cell Lung Cancer (NSCLC)TerminatedNCT03198117Not applicable
- mil60 Versus Bevacizumab in Patients With Treatment-naïve Non-squamous Non-small Cell Lung CancerCompletedNCT03196986Phase 3
- To Predict Efficacy by Detecting Circulating Endothelial Cell Subsets and Blood Perfusion Parameters Changes in Vivo Tumor in Study of QL1101 and Avastin® in Patients With Non-squamous Non-small Cell Lung CancerStatus unknownNCT03195569
- Efficacy and Safety of Maintenance Apatinib Combined With Pemetrexed in Advanced Non-squamous Non-small Cell Lung Cancer PatientsWithdrawnNCT03190239Phase 2
- Comparison of Diagnostic and Therapeutic Efficacy of EBUS-TBNA/EUS-FNA and TEMLA in Operable NSCLC.CompletedNCT03188562Not applicable
- A Study to Evaluate the Efficacy and Safety of Multiple Targeted Therapies as Treatments for Participants With Non-Small Cell Lung Cancer (NSCLC)Active, not recruitingNCT03178552Phase 2/3
- Expanded Access For Lorlatinib For Patients With Non Small Cell Lung Cancer ALK Positive or ROS1 PositiveNo longer availableNCT03178071
- Pirfenidone Combined With Standard First-Line Chemotherapy in Advanced-Stage Lung NSCLCCompletedNCT03177291Phase 1
- Dexamethasone, Flurbiprofen Axetil and Long-term Survival After Lung Cancer SurgeryTerminatedNCT03172988Phase 4
- ctDNA Dynamic Monitoring and Its Role of Prognosis in Stage I NSCLS by NGSCompletedNCT03172156
- Study of Cabozantinib Alone or in Combination With Atezolizumab to Subjects With Locally Advanced or Metastatic Solid TumorsActive, not recruitingNCT03170960Phase 1
- Observational Study to Evalute the Efficacy and Safety of Avastin (Bevacizumab) in Addition to Platinum-Based Chemotherapy for First-Line Treatment of Participants With Non-Small Cell Lung CancerCompletedNCT03170284
- QUILT-3.044: NANT Non-small Cell Lung Cancer (NSCLC) Vaccine: Combination Immunotherapy in Subjects With NSCLC Who Have Progressed After Treatment With PD-1/PD-L1 InhibitorsWithdrawnNCT03169738Phase 1/2
- Efficacy and Safety of QL1101 and Avastin® Respectively Combined With Paclitaxel and Carboplatin in the First-line Treatment of Non-squamous Non-small Cell Lung CancerCompletedNCT03169335Phase 3
- Personalized Therapeutic Anti-tumor Vaccine With Pembrolizumab and Standard of Care Chemotherapy in Squamous Non-Small Cell Lung Cancer and Extensive Stage Small Cell Lung CancerWithdrawnNCT03166254Phase 1
- UCDCC#270: Avelumab and Stereotactic Ablative Radiotherapy in Non-responding and Progressing NSCLC PatientsCompletedNCT03158883Early Phase 1
- Bone Metastasis on the Survival of Gefitinib Effective PatientsCompletedNCT03157310Not applicable